Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.
Whole-body in vivo monitoring of inflammatory diseases exploiting human interleukin 6-luciferase transgenic mice.
Olfactory bulb and olfactory sulcus depths are associated with disease duration and attack frequency in multiple sclerosis patients.
HIV immunodynamics and multiple sclerosis.
[Concepts and epidemiology of combined central and peripheral demyelination].
Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis.
[Alemtuzumab for relapsing-remitting multiple sclerosis : Results of two randomized controlled phase III studies.]
Implementing technology-based embedded assessment in the home and community life of individuals aging with disabilities: a participatory research and development study.
Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients.
Demyelination complicating anti-tnf therapy in inflammatory bowel disease (ibd) and other inflammatory disorders (pred4-ukcrn 11988).
Optical tomographic imaging of near infrared imaging agents quantifies disease severity and immunomodulation of experimental autoimmune encephalomyelitis in vivo.
Abnormal nerve conduction study findings indicating the existence of peripheral neuropathy in multiple sclerosis and neuromyelitis optica.
18F-DOPA, a Clinically Available PET Tracer to Study Brain Inflammation?
Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies.
Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature.
Glutamate Release Machinery Is Altered in the Frontal Cortex of Rats with Experimental Autoimmune Encephalomyelitis.
Biomarkers of interferon Beta therapy in multiple sclerosis.
Human aquaporin 4 gene polymorphisms in Chinese patients with neuromyelitis optica.
Falls in people with MS who use a walking aid: Prevalence, factors and effect of balance and strengthening interventions.
Cellular immune responses in multiple sclerosis patients treated with interferon-beta.
Serum exosomes in pregnancy-associated immune modulation and neuroprotection during CNS autoimmunity.
Disability caused by multiple sclerosis is associated with the number of extra cranial venous stenoses: possible improvement by venous angioplasty. Results of a prospective study.
Substituted 7-Amino-5-thio-thiazolo[4,5-d]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX3CR1).
Perception of muscular effort in multiple sclerosis.
Large-scale production of human mesenchymal stem cells for clinical applications.
Pages
« first
‹ previous
…
499
500
501
502
503
504
505
506
507
…
next ›
last »